Note since this post was made on 9/9/08 more research has been published which makes a stronger case that inhibiting DPP-4 is a trigger for prostate cancer and enhances the metastatic activity of ovarian, lung and melanoma cancers. To learn more about these findings and follow the citations to the published research, visit this page:Januviaand scroll to the section titled "Research Connecting
